Executive record

Quang X. Pham

Most recent record: Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO (named as the outgoing officer), effective June 25, 2026.

2 verified records · 1 company

Career line from the records

2

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-06-29InterimCadrenal Therapeutics, Inc.

    Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO

    Named as the outgoing officer

    effective June 25, 2026 · 8-K filed June 29, 2026 · sec.gov, Item 5.02

  2. 2026-06-03InterimCadrenal Therapeutics, Inc.

    Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO

    Named as the incoming officer, interim Chief Financial Officer and interim Principal Accounting Officer

    effective May 28, 2026 · 8-K filed June 3, 2026 · sec.gov, Item 5.02

Companies

1

Cadrenal Therapeutics, Inc.CVKD

Pharmaceutical Preparations

This page lists only verified filing records that name Quang X. Pham, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.